<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04964596</url>
  </required_header>
  <id_info>
    <org_study_id>2022-10019</org_study_id>
    <nct_id>NCT04964596</nct_id>
  </id_info>
  <brief_title>Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic</brief_title>
  <official_title>Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to offer and evaluate an interim triage approach for&#xD;
      patients waiting for surveillance colonoscopies. This will reduce the waiting period and the&#xD;
      psychological stressors for our patients and from a scientific point of view allow us to&#xD;
      compare the yield of findings for each approach.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 26, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients who meet the eligibility requirements will be randomized in a double-blind manner (participant and investigator) in a 1:1:1 ratio into 3 groups</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of detection of neoplastic colon polyp</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparaison of neoplastic colon polyp number detected between CTC and colonoscopy</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients on the list having a positive or negative FIT test or CTC and diagnosed with advanced neoplasia, non-advanced CR neoplasia, CR cancerous and precancerous lesions on colonoscopy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients on the list having a CTC and diagnosed with advanced neoplasia, non-advanced CR neoplasia, CR cancerous and precancerous lesions on colonoscopy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Adenomatous Polyps</condition>
  <arm_group>
    <arm_group_label>a colonoscopy as surveillance exam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will undergo Colonoscopy, finding will be documented. Findings of colonoscopy will be documented and treated according to the institutional standards. Study participation for patients ends after the colonoscopy and follow-up of pathology results and complication assessment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>undergoing a FIT as surveillance exam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>if the FIT test is positive: patients will have subsequent colonoscopy within 3 months. Findings of FIT testing and if positive the colonoscopy will be documented and participation in the study will end after that. Findings of the FIT test and colonoscopy will be treated according to the institutional standards. If FIT test is negative patient will leave the study and will have a follow up with a colonoscopy or FIT test in 1 to 2 years outside of this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>undergoing CT colonography as surveillance exam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>If CTC is positive: patients will have subsequent colonoscopy within 3 months. Findings will be documented and participation in the study will end there. Findings of the colonoscopy will be addressed according to our institution's guidelines. If CTC is negative for polypoid lesions patient will leave the study and will have a follow up 5 years after with either a CTC or colonoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>colonoscopy</intervention_name>
    <description>colonoscopy</description>
    <arm_group_label>a colonoscopy as surveillance exam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FIT test</intervention_name>
    <description>faecal immunochemical test</description>
    <arm_group_label>undergoing a FIT as surveillance exam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CT colonography</intervention_name>
    <description>noninvasive medical imaging technique that uses computed tomography to visualize the interior of the colon and rectum especially to screen for polyps or cancerous growths</description>
    <arm_group_label>undergoing CT colonography as surveillance exam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - people with referral sheets for surveillance colonoscopies : meaning 3 or 5 years after&#xD;
        the initial colonoscopy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known or suspected acute diverticulitis&#xD;
&#xD;
          -  ulcerative colitis&#xD;
&#xD;
          -  Crohn's disease&#xD;
&#xD;
          -  toxic megacolon&#xD;
&#xD;
          -  acute abdominal pain&#xD;
&#xD;
          -  familial polyposis syndrome&#xD;
&#xD;
          -  coagulopathy&#xD;
&#xD;
          -  poor general health (defined as an American Society of Anaesthesiologists class &gt;3)&#xD;
&#xD;
          -  patients presenting for emergency colonoscopies&#xD;
&#xD;
          -  patients incapable of lying flat on their back for the duration of the CT colonography&#xD;
             due CHF or other predispositions&#xD;
&#xD;
          -  patients with a personal history of CRC&#xD;
&#xD;
          -  patient undergoing colonoscopy for surveillance after EMR or ESD procedures&#xD;
&#xD;
          -  patients diagnosed with a CRC or a metastatic cancer&#xD;
&#xD;
          -  patients with a history of contrast allergies&#xD;
&#xD;
          -  Patients referred for polypectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Polyps detection</keyword>
  <keyword>triage approach</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Adenomatous Polyps</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

